Australia's Melodiol Global Health jumps on strong revenue growth

Melodiol Global Health

03/07/2024 01:51

** Shares of Melodiol Global Health  ME1.AX  rise as much as
25% to A$0.005, highest since June 26    
    ** Cannabis co says Q2 2024 unaudited revenue A$4.8 mln
($3.20 mln), a 9% increase on Q1 2024
    ** Adds H1 2024 unaudited revenue A$9.2 mln, a 31% increase
on H1 2023 
    ** ME1 down 99.7% YTD, as of last close

($1 = 1.4993 Australian dollars)

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))